Skip to main content
Figure 6 | BMC Surgery

Figure 6

From: Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification

Figure 6

Patient survival stratified for intratumoral Cyclin D1 and IL-17A expression. (A) No statistically significant survival difference was noted between patients with low (N=20) and high (N=17) expression of Cyclin D1 (86 ± 11 versus 92 ± 15 months; P=0.795). (B) There was a trend to reduced patient survival time in case of low (N=22) intratumoral IL-17A expression compared to high (N=15) IL-17A expression though the difference was not statistically significant (87 ± 14 versus 117 ± 11 months; P=0.211).

Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us